Literature DB >> 27831539

Incidence and prevalence of systemic lupus erythematosus among the native Arab population in UAE.

A M Al Dhanhani1, M Agarwal2, Y S Othman3, O Bakoush1.   

Abstract

Background and objectives There is a paucity of information about the epidemiology of systemic lupus erythematosus (SLE) amongst Arabs. The objective of this study was to determine the incidence and prevalence of SLE among the native Arab population of United Arab Emirates (UAE). Methods Patients with SLE were identified from three sources: medical records of two local tertiary hospitals (four years; 2009 to 2012), laboratory requests for serum double stranded deoxyribonucleic acid and serum anti-nuclear antibody and confirmed histopathologic diagnosis of SLE (skin and kidney biopsy specimens). All the patients identified with SLE met the criteria of the American College of Rheumatology. Incidence and prevalence were calculated using the state records of the UAE native population as the denominator. The age-adjusted incidence was calculated by direct standardization using the World Health Organization world standard population 2000-2025. Results Sixteen new cases (13 females and three males) fulfilled the American College of Rheumatology SLE criteria. The mean (±SD) age at time of diagnosis was 28.6 ± 12.4 years. The crude incidence ratio (per 100,000 population) was 3.5, 1.1, 2.1 and 2.1 in years 2009, 2010, 2011, 2012, respectively. The age-standardized incidence per 100,000 population for the four years was 8.6 (95% confidence interval 4.2-15.9). The age-standardized prevalence of SLE among the native population according to the 2012 population consensus was 103/100,000 population (95% confidence interval 84.5-124.4). Conclusion The age-adjusted incidence and prevalence among UAE Arabs is higher than has been reported among most other Caucasian populations. Furthermore, the prevalence of SLE in UAE seems much higher than other similar Arab countries in the Gulf region.

Entities:  

Keywords:  Incidence; UAE; prevalence; systemic lupus erythematosus

Mesh:

Year:  2016        PMID: 27831539     DOI: 10.1177/0961203316678677

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

Review 1.  Epidemiology of systemic lupus erythematosus: an update.

Authors:  George Stojan; Michelle Petri
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

2.  National systemic lupus erythematosus prospective cohort in Saudi Arabia: A study protocol.

Authors:  Ibrahim A Almaghlouth; Lena M Hassen; Hana S Alahmari; Asma Bedaiwi; Rana Albarrak; Maha Daghestani; Eman Alqurtas; Abdulaziz Alkhalaf; Mohammed Bedaiwi; Mohammed Omair; Sultan Almogairen; Hussein Alarfaj; Abdulrahman Alarfaj
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

Review 3.  Major histocompatibility complex (MHC) associations with diseases in ethnic groups of the Arabian Peninsula.

Authors:  Halima Al Naqbi; Aurélie Mawart; Jawaher Alshamsi; Habiba Al Safar; Guan K Tay
Journal:  Immunogenetics       Date:  2021-02-02       Impact factor: 2.846

4.  Association of <em>TNFAIP3</em> gene polymorphism (<em>rs5029939</em>) with susceptibility and clinical phenotype of systemic lupus erythematosus.

Authors:  Hala Gaballah; Reham Abd-Elkhalek; Ola Hussein; Shimaa Abd El-Wahab
Journal:  Arch Rheumatol       Date:  2021-10-16       Impact factor: 1.472

5.  Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus.

Authors:  Richard A Furie; Ian N Bruce; Thomas Dörner; Manuel Gustavo Leon; Piotr Leszczyński; Murray Urowitz; Birgit Haier; Teri Jimenez; Claire Brittain; Jiajun Liu; Catherine Barbey; Christian Stach
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.046

Review 6.  Global epidemiology of systemic lupus erythematosus.

Authors:  Megan R W Barber; Cristina Drenkard; Titilola Falasinnu; Alberta Hoi; Anselm Mak; Nien Yee Kow; Elisabet Svenungsson; Jonna Peterson; Ann E Clarke; Rosalind Ramsey-Goldman
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 32.286

7.  Maternal and fetal complications associated with systemic lupus erythematosus: An updated meta-analysis of the most recent studies (2017-2019).

Authors:  Wen Rong He; Hua Wei
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.